Chemed Corporation

NYSE:CHE

Medical - Care Facilities

Healthcare
$546.72 +1.13%

+$4.91 today

Market cap
$7.12B
Beta
0.54
P/E (TTM)
23.2
EPS (TTM)
$19.00
Dividend yield
0.54%
52W Low $365.21High $562.77

Volume 0.17M

Average 0.25M

CHE Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Chemed CorporationNYSE: CHE

Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026

Deferred revenue remains negative

Q2 FY2026 deferred revenue was $0, compared with $0 a year earlier.

Context

  • Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Deferred revenue increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoJun 2025
$0— since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Deferred Revenue vs competitors

How CHE compares with its peers on the latest reported figures

  • CHE's Jun 2026 deferred revenue of $0 is the 3rd highest of the 5 companies compared; the peer median is $1.26M.
  • Deferred revenue amounts to 0.0% of total assets for CHE, versus a peer median of 0.1%.
CHE Competitors Peer median
Deferred Revenue for CHE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ADUSAddus HomeCare CorporationJun 2026$12.38M +56.2%—0.9%
PNTGThe Pennant Group, Inc.Mar 2026$2.52M +7.7%+12.9%0.3%
CHEChemed CorporationJun 2026$0 ——0.0%
OPCHOption Care Health, Inc.Sep 2026$0 ——0.0%
AVAHAveanna Healthcare Holdings Inc.Oct 2026$0 ——0.0%
Peer median (excluding CHE) $1.26M+32.0%+12.9%0.1%

Competitors are the stored peer set for CHE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents32.9M74.13M263.96M178.35M74.52M
Short-term Investments00000
Net Receivables137.22M139.41M181.51M171.16M182.58M
Inventory10.11M10.27M12M8.19M7.54M
Other Current Assets00000
Total Current Assets230.29M272.61M500.84M394.75M302.62M
Property, Plant & Equipment (Net)318.73M335.38M330.23M328.16M336.81M
Goodwill578.59M581.3M585.02M666.74M667M
Intangible Assets108.1M99.73M90.26M92.21M82.76M
Long-term Investments98.88M000140.35M
Tax Assets0000101.82M
Other Non-current Assets8.14M153M161.74M186.72M8.65M
Total Non-current Assets1.11B1.17B1.17B1.27B1.34B
Total Assets1.34B1.44B1.67B1.67B1.64B
Account Payables73.02M41.88M64.03M44.15M53.46M
Short-term Debt05M15.7M051.89M
Tax Payables41K18.52M6.86M7.59M11.17M
Deferred Revenue00000
Other Current Liabilities134.63M145.84M121.87M134.75M120.95M
Total Current Liabilities302.4M297.21M312.05M285.7M287.13M
Long-term Debt185M92.5M000
Deferred Tax Liabilities23.18M38.61M30.32M25.95M121.14M
Deferred Revenue (Non-current)0000136.14M
Other Non-current Liabilities108.24M104.47M117.07M139.4M13.34M
Total Non-current Liabilities417.05M346.09M248.17M263.89M373.48M
Total Liabilities719.45M643.3M560.22M549.58M660.61M
Common Stock36.51M36.8M37.18M37.42M37.6M
Retained Earnings1.97B2.2B2.45B2.72B2.96B
Accumulated OCI00002.36M
Other Stockholders Equity2.2M2.25M2.08M2.22M0
Minority Interest00000
Total Equity623.27M798.72M1.11B1.12B979.41M
Total Debt323.54M247.01M155.11M140.84M154.76M
Net Debt290.65M172.88M(108.85M)(37.51M)80.24M

Chemed Corporation

NYSE:CHE

Intrinsic Alpha fair value

Locked

Current Price

$546.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.